Hyperbilirubinaemia | List of Frontiers open access articles

Original Research

Published on 08 Feb 2021

Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ

in Drug Metabolism and Transport

Ya-Di Zhu
Xiao-Qing Guan
Jing Chen
Sheng Peng
Moshe Finel
Ying-Yuan Zhao
Rui-Min Wang
Hui-Chang Bi
Ming Lei
Dan-Dan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.628314

11,561 views
31 citations

Mini Review

Published on 13 Jan 2026

Bilirubin-microbiota interaction: molecular mechanisms and therapeutic strategies in neonatal jaundice

in Microorganisms in Vertebrate Digestive Systems

Wenlong Yan
Ning Du
Kun Zhang
Pingping Yang
Jing Guo
Lingfen Xu

Frontiers in Microbiology

doi 10.3389/fmicb.2025.1749152

1,502 views

Case Report

Published on 30 Apr 2026

A case report of neonatal renal pseudohypoaldosteronism type I caused by a de novo variant in the NR3C2 gene

in Pediatric Nephrology

Hongcai Ma
Huijiao Han
Yanyan Liu
Yong An

Frontiers in Pediatrics

doi 10.3389/fped.2026.1774632

402 views

Methods

Published on 17 Dec 2021

Technical Note: Novel Use of CytoSorb™ Haemadsorption to Provide Wound Healing Support in Case of Severe Burn Trauma via Reduction of Hyperbilirubinaemia

in Reconstructive and Plastic Surgery

Katarzyna Rachunek
Maja Krause
Johannes Tobias Thiel
Jonas Kolbenschlag
Adrien Daigeler
Andreas Bury

Frontiers in Surgery

doi 10.3389/fsurg.2021.743571

5,529 views
8 citations

Original Research

Published on 21 Feb 2022

Discovery and Characterization of the Key Constituents in Ginkgo biloba Leaf Extract With Potent Inhibitory Effects on Human UDP-Glucuronosyltransferase 1A1

in Ethnopharmacology

Hui-Lin Pang
Guang-Hao Zhu
Qi-Hang Zhou
Chun-Zhi Ai
Ya-Di Zhu
Ping Wang
Tong-Yi Dou
Yang-Liu Xia
Hong Ma
Guang-Bo Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2022.815235

4,512 views
9 citations

Original Research

Published on 25 Jan 2021

Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2

in Experimental Pharmacology and Drug Discovery

Claudia A. Hana
Eva-Maria Klebermass
Theresa Balber
Markus Mitterhauser
Ruth Quint
Yvonne Hirtl
Antonia Klimpke
Sophie Somloi
Juliana Hutz
Elisabeth Sperr

Frontiers in Pharmacology

doi 10.3389/fphar.2020.636533

7,392 views
11 citations

Articles

Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ

Bilirubin-microbiota interaction: molecular mechanisms and therapeutic strategies in neonatal jaundice

A case report of neonatal renal pseudohypoaldosteronism type I caused by a de novo variant in the NR3C2 gene

Technical Note: Novel Use of CytoSorb™ Haemadsorption to Provide Wound Healing Support in Case of Severe Burn Trauma via Reduction of Hyperbilirubinaemia

Discovery and Characterization of the Key Constituents in Ginkgo biloba Leaf Extract With Potent Inhibitory Effects on Human UDP-Glucuronosyltransferase 1A1

Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2